Citigroup Inc Merck & Co., Inc. Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citigroup Inc holds 4,422,193 shares of MRK stock, worth $434 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
4,422,193
Previous 6,656,934
33.57%
Holding current value
$434 Million
Previous $824 Million
39.06%
% of portfolio
0.3%
Previous 0.54%
Shares
13 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...